Aap Implantate AGAAQX:GER

2.43
0.013 / 0.54%
714
60.49%
0.6193
Close in EURToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Oct 31 2014 16:36 GMT.

About the company

35.60m-4.16m1997195
Revenue in EUR (TTM)Net income in EURIncorporatedEmployees
IndustryHealth Care Equipment & ServicesLocation
Aap Implantate AG
Lorenzweg 5
BERLIN12099
Germany
DEU
Phone+49 30750190Fax+49 3 075019111Websitehttp://www.aap.de
aap Implantate AG is a Germany-based provider of biomedical implants for human muscular and skeletal systems. The Company is divided into two segments: Trauma and Orthopedics, active in the field of endoprosthetics and osteosynthesis, and Biomaterials, active in the field of orthobiology. Osteosynthesis products include nails, screws and plates to temporarily hold bones together while they knit. Endoprosthetic products include replacement hip and knee joints. In the field of orthobiology, the Company is engaged in the research and development of bone substitute materials, largely through its aap Biomaterials GmbH & Co. KG subsidiary, a specialty development and production company active in the tissue-engineering sector. The Company is also engaged in the supply of bone cements and special cementing techniques. In June 2013, it entered a joint venture with a private equity company. The private equity company acquired 67% of the Company's subsidiary aap Joints GmbH.

Mergers & acquisitions

There are no recent mergers or acquisitions for Aap Implantate AG.
Data delayed at least 15 minutes, as of Oct 31 2014 16:36 GMT.

Peer analysis

Company Revenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings
(TTM)
Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excluding
extraordinary items (TTM)
EPS (including
extraordinary items) (TTM)
Revenue per
share (TTM)
Book value per
share (MRQ)
Asset turnover
(TTM)
Inventory turnover
(TTM)
Receivables turnover
(TTM)
Revenues per
employee (TTM)
Return on
average
assets
(TTM)
Return on
average
assets
(5 yr average)
Return on
investment
(TTM)
Return on
investment
(5 yr average)
Gross margin (TTM)Gross margin (5 yr average)Net profit margin (TTM)Net Profit margin (5 Yr Average)Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio (5 yr average)Revenue
(Year-over-year change%)
Revenue
(5 yr growth rate)
Net income
(Year-over-year change%)
Net income
(5 Yr growth rate)
Capital
expenditure
(5 Yr growth rate)
Dividend
(5 yr growth rate)
ifa systems AG
7.89m1.11m16.54m7214.871.137.322.090.44480.44483.165.880.420214.016.61109,6395.928.776.348.7775.6969.4514.0913.731.3834.820.051321.654.995.4682.0211.54--4.56
Geratherm Medical AG
17.00m1.44m39.35m13027.281.9919.832.310.29150.29153.443.990.62271.455.37146,5814.647.835.367.8354.6856.907.4410.313.48--0.202479.445.3710.0911.69---5.6609--
aap Implantate AG
35.60m-4.16m74.22m195--1.5315.422.08-0.1352-0.13521.151.580.57060.95786.04150,224-6.66650.9173-7.46320.917370.9080.13-11.68441.364.08-47.70460.12150.009.823.27-201.8257--6.40--
Data as of Oct 31 2014. Currency figures normalised to Aap Implantate AG's reporting currency: Euro EUR.

Institutional shareholders

There are no institutional shareholders for Aap Implantate AG.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.